Though the analysis of the included studies did not find evidence of vasopressin V2 receptor antagonists extending cirrhosis patients’ lifetime, we could not ignore this effect easily considering the remarkable effects of elevating serum sodium concentration and improvement of ascites. The gene discussed is AVPR2; the disease is Cirrhosis.